Scott Dahlbeck

Scott Dahlbeck

Chief Medical Officer And Head Of Clinical Operations, @ Kiromic BioPharma

About Scott Dahlbeck

Scott Dahlbeck: Chief of Staff

Scott Dahlbeck currently serves as the Chief of Staff. With extensive experience in medical and oncology commerce, his leadership is backed by a solid medical background. He previously held the position of President from January 2013 to October 2019 and later transitioned to the role of Chief Medical Officer from October 2019 to February 2022.

Scott Dahlbeck Education

Scott Dahlbeck earned his MD from the University of Texas Health Science Center at Houston. Further bolstering his medical expertise, he earned a PharmD degree from the University of Nebraska Medical Center, College of Pharmacy. His educational background has provided a strong foundation for his prolific career in medicine and oncology.

Scott Dahlbeck Expertise in Prostate Cancer Research

Scott Dahlbeck is an expert in prostate cancer research and treatment. His extensive knowledge and practical experience in this area have made significant contributions to the field. He has also served as a Radiation Oncologist for several cancer centers, providing specialized care in oncology.

Scott Dahlbeck Adjunct Assistant Professor

Scott Dahlbeck has served as an Adjunct Assistant Professor in Internal Medicine, Pathology, and Urology at the Texas Tech University Health Sciences Center. His role as an educator complements his hands-on medical practice, contributing to the training and development of future medical professionals.

Scott Dahlbeck Patents and Commercial Ventures

Scott Dahlbeck has patented, manufactured, and commercialized intellectual property. His work in this area highlights his ability to innovate and bring new medical solutions to market. This aspect of his career underscores his impact on both the medical and commercial facets of oncology.

People similar to Scott Dahlbeck